Late appearance of JAK2 mutated polycythaemia vera in a patient with typical chronic myeloid leukaemia on imatinib: Speculations about role of therapeutic pressure and of secondary genetic events.Gianfranco Lapietra, Maria Zaira Limongi, Sonia Buffolino, Mauro Nanni, Daniele Ballarò, Maurizio Martelli, Marco Mancini
No abstract text is available yet for this article.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
You can now claim free CME credits for this literature searchClaim now